IP Verse

Neymeyr competitive analysis

Explore patent oppositions filed by Neymeyr against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 6, 2026

Patent Number	Title	Applicant	Opposition Date
EP4057482	Method And Device For Estimating The Condition Of An Electrical Network	SIEMENS	Jun 24, 2026
EP3836920	Formulations Of Ag10	EIDOS THERAPEUTICS	Jun 23, 2026
EP4406594	Method Of Synthesizing Thyroid Hormone Analogs And Polymorphs Thereof	F HOFFMANN LA ROCHE	Jun 9, 2026
EP3411021	New Use Of A Combination Of Sacubitril And Valsartan	NOVARTIS	Feb 12, 2026
EP4212152	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Jan 29, 2026
EP3592732	Manufacture Of A Crystalline Pharmaceutical Product	ORION	Jan 9, 2026
EP3470400	Crystal Form Of Ozanimod, Crystal Form Of Hydrochloride Thereof, And Preparation Method Therefor	CRYSTAL PHARMACEUTICAL SUZHOU	Dec 23, 2025
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 16, 2025
EP4125903	Methods For Dose Initiation Of Aripiprazole Treatments	OTSUKA PHARMACEUTICAL	Jul 1, 2025
EP4097091	Solid State Forms Of Mavacamten And Process For Preparation Thereof	ASSIA CHEMICAL INDUSTRIES	Jun 17, 2025

Discover the latest PTAB cases involving Neymeyr, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Neymeyr with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 6, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
DR SCHON	34	-	-	-
F HOFFMANN LA ROCHE	16	195	-	-
IT SEAL	-	4	-	-
NOVARTIS	6	472	-	21